MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Subthalamic Nucleus Stimulation Modulates Cognitive Theory of Mind in Parkinson’s Disease

    HY. Xiao, LQ. Lang, Z. Ye, JJ. Wu (Shanghai, China)

    Objective: This study aims to investigate the effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on ToM using the Parkinson’s disease (PD) model. Background:…
  • 2024 International Congress

    Peripheral immunity and clinical phenotypes in patients with ventriculomegaly

    C. Espinoza-Vinces, I. Avilés-Olmos, G. Martí-Andrés, M. Jiménez-Vázquez, M. Calvo-Imirizaldu, M. Marín Gracia, R. Villino-Rodríguez, A. Atorrasagasti-Villar, J. Arbizu, MR. Luquin (PAMPLONA, Spain)

    Objective: To characterize the neutrophil-to-lymphocyte ratio (NLR) levels in the peripheral blood of patients with ventriculomegaly and its correlation with clinical outcomes Background: Ventriculomegaly is…
  • 2024 International Congress

    Dual-Task Cost of Walking While Using a Smartphone: A Comparison Study of Older Adults with and Without Cognitive Decline

    G. Christofoletti, T. Lino, S. Sobrinho Junior (Campo Grande, Brazil)

    Objective: To investigate spatiotemporal gait parameters in older adults with and without cognitive decline while walking in the presence of smartphone use. Background: The use…
  • 2024 International Congress

    A Phase 2 Study of ATH434 a Novel Inhibitor of α-Synuclein Aggregation for the Treatment of Multiple System Atrophy

    D. Stamler, C. Wong, P. Trujillo, M. Bradbury, C. Lucas, D. Claassen (Newark, USA)

    Objective: Describe baseline fluid and neuroimaging biomarker data of an early MSA study population Background: MSA is a rapidly progressive neurodegenerative disorder characterized by aggregated…
  • 2024 International Congress

    Blood-brain Barrier Breakdown in Dementia with Lewy Bodies

    ZC. Chen, J. Gan, Y. Ji (Beijing, China)

    Objective: To explore the characteristics of BBB breakdown in DLB and find the correlation between leakage and cognitive domains. Background: These years, researchers found that…
  • 2024 International Congress

    Parkinsonism due to Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Responsive to Carbidopa/Levodopa

    P. Hoff, F. Butt (Oklahoma City, USA)

    Objective: To describe a case of Parkinsonism due to ALSP which is responsive to carbidopa/levodopa Background: Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)…
  • 2024 International Congress

    Driving assessment in older patients with Parkinson’s in United Kingdom.

    M. Khwaja, T. Nanayakkara, G. Pun, R. Miah, N. Butt, A. Chatterjee (Reading, United Kingdom)

    Objective: To review existing pathway for driving assessment in older Parkinson’s patients in Royal Berkshire Hospital, Reading, UK. Background: Parkinson’s leads to motor, cognitive and…
  • 2024 International Congress

    The Challenges of Very Late-Onset Parkinson’s Disease: Perspectives from Patients, Primary Caregivers and Attending Physicians.

    S. Okusa, R. Okouchi, Y. Sakai, T. Nukariya, T. Tezuka, Y. Nihei, J. Nakahara, M. Seki (Tokyo, Japan)

    Objective: The purpose of this study is to investigate the difficulties faced by very late-onset patients with Parkinson’s disease (PD), caregivers and attending physicians, and…
  • 2024 International Congress

    Misdiagnosis of Cognitive Impairment in Parkinson’s disease

    F. Rodriguez-Porcel, T. Turner (Charleston, USA)

    Objective: We explored potential bias to diagnose cognitive impairment in People with Parkinson’s (PwP) followed in the Parkinson’s Progressive Markers Initiative (PPMI). Background: In primary…
  • 2024 International Congress

    Catalan MSA Registry (CMSAR): Applying new Clinical Criteria and Biomarkers for Increasing Diagnostic Accuracy, is New Better?

    A. Pérez-Soriano, C. Painous, J. Pérez, M. Fernandez, Y. Compta, Consortium, MJ. Martí (Barcelona, Spain)

    Objective: To reassess the CMSAR and determine if new criteria and new biomarkers can enhance diagnostic accuracy. Background: The CMSAR, conducted between 2015 and 2019,…
  • « Previous Page
  • 1
  • …
  • 109
  • 110
  • 111
  • 112
  • 113
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley